by
According to the Foreclaro Global Research, the
Global
Ocular Drug Delivery Devices Market size was valued at USD 14071.6 million in 2024. The report “Global
Ocular Drug Delivery Devices Market Segmentation By Product Type
(Ocular Inserts {Biodegradable Inserts, Non-Biodegradable Inserts}, Drug-Coated
Contact Lenses, Intraocular Implants {Biodegradable Implants, Non-Biodegradable
(Sustained-Release) Implants}, Ocular Injections {Intravitreal Injections, Subconjunctival
Injections, Retrobulbar Injections}, Minimally Invasive Glaucoma Surgery (MIGS)
Devices), By Technology (Biodegradable Technology, Implantable Technology, Particulate
Technology, Iontophoresis Technology), By Disease Indication (Glaucoma, Diabetic
Retinopathy, Macular Degeneration, Diabetic Macular Edema, Uveitis, Cataracts, Other
Retinal Diseases), By End-User (Hospitals, Ophthalmic Clinics, Ambulatory
Surgical Centres, Homecare Settings)- Industry Trends and Forecast to 2033” gives a detailed insight into current market
dynamics and provides analysis on future market growth.
The global ocular drug delivery devices
marketplace is experiencing strong growth, pushed through growing incidences of
eye problems along with glaucoma, diabetic retinopathy, macular degeneration,
and uveitis. Traditional eye drops and systemic treatment options regularly
face boundaries like bad bioavailability and speedy drug clearance, growing a
sturdy demand for superior and sustained-launch drug shipping structures.
Innovative gadgets along with ocular implants, drug-covered touch lenses, and
minimally invasive glaucoma surgery (MIGS) gadgets are revolutionizing
ophthalmic remedy through enhancing drug retention and affected person
compliance. Technological improvements in biodegradable and implantable
shipping structures similarly beautify healing precision and decrease dosing
frequency. Moreover, growing R&D investments, favorable regulatory
approvals, and strategic partnerships amongst biotech and scientific tool
businesses are boosting marketplace expansion. However, excessive expenses and
surgical complexities might also additionally restriction adoption in
low-profits regions. Overall, the marketplace is poised for substantial growth,
emphasizing innovation, long-appearing formulations, and affected
person-centric ocular care solutions.
Have any questions or need more information?
Click the link below to request a sample or make an inquiry before making your
purchase:
https://foreclaroglobalresearch.com/research-report/global-ocular-drug-delivery-devices-market
Global Ocular
Drug Delivery Devices Market Report Highlights
· The
global ocular drug delivery devices marketplace is projected to develop notably
because of growing instances of glaucoma, diabetic retinopathy, and macular
degeneration worldwide.
· Rising
adoption of biodegradable, implantable, and particulate technology is improving
drug bioavailability and long-time period healing outcomes.
· Launches
of sustained-launch implants, drug-covered touch lenses, and MIGS gadgets are
revolutionizing centered and minimally invasive ophthalmic drug shipping.
· Key
gamers consisting of Glaukos, Alcon, Regeneron, and Merck are riding
marketplace growth thru acquisitions, collaborations, and new product launches.
· North
America dominates the marketplace because of superior healthcare
infrastructure, whilst Asia-Pacific is the fastest-developing region, pushed
with the aid of using growing healthcare consciousness and investment.
· The
marketplace is predicted to witness sturdy long-performing and patient-pleasant
ocular drug shipping systems, supported with the aid of using ongoing R&D
and regulatory support.
Foreclaro
Global Research has segmented the Ocular Drug Delivery Devices Market report
based on Product Type, technology, Components, Functionality, End User Industry
and region:
Ocular
Drug Delivery Devices Market, Product Type Outlook (Revenue - USD Million, 2020
- 2033)
Ocular
Inserts
·
Biodegradable
Inserts
·
Non-Biodegradable
Inserts
Drug-Coated
Contact Lenses
Intraocular
Implants
·
Biodegradable
Implants
·
Non-Biodegradable
(Sustained-Release) Implants
Ocular
Injections
·
Intravitreal
Injections
·
Subconjunctival
Injections
·
Retrobulbar
Injections
Minimally
Invasive Glaucoma Surgery (MIGS) Devices
Ocular
Drug Delivery Devices Market, Technology Outlook (Revenue - USD Million, 2020 -
2033)
Biodegradable
Technology
Implantable
Technology
Particulate
Technology
Iontophoresis
Technology
Ocular
Drug Delivery Devices Market, Disease Indication Outlook (Revenue - USD
Million, 2020 - 2033)
Glaucoma
Diabetic
Retinopathy
Macular
Degeneration
Diabetic
Macular Edema
Uveitis
Cataracts
Other
Retinal Diseases
Ocular
Drug Delivery Devices Market, End User Outlook (Revenue - USD Million, 2020 -
2033)
Hospitals
Ophthalmic
Clinics
Ambulatory
Surgical Centers
Homecare
Settings
Ocular
Drug Delivery Devices Market, Regional Outlook (Revenue - USD Million, 2020 -
2033)
North
America
·
United
States
·
Canada
·
Mexico
Europe
·
United
Kingdom
·
Germany
·
France
·
Spain
·
Italy
·
Rest
of Europe
Asia
Pacific
·
China
·
India
·
Japan
·
Australia
·
South
Korea
·
Rest
of Asia Pacific
Latin
America
·
Brazil
·
Argentina
·
Rest
of Latin America
Middle East
& Africa
·
Saudi
Arabia
·
South
Africa
·
Rest
of MEA
Global Ocular Drug Delivery Devices Market Key Players
·
Bausch Health Companies Inc.
·
Taiwan Liposome Company, Ltd.
·
Ocular Therapeutix, Inc.
·
Kiora Pharmaceuticals, Inc.
·
Graybug Vision Inc.
·
Apellis Pharmaceuticals, Inc.
·
Implanet Company
·
Aerie Pharmaceuticals Inc.
·
EyePoint Pharmaceuticals, Inc.
·
Protalix BioTherapeutics
